W Dankner
Overview
Explore the profile of W Dankner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ball P, Mandell L, Patou G, Dankner W, Tillotson G
Int J Antimicrob Agents
. 2004 May;
23(5):421-9.
PMID: 15120718
Gemifloxacin is a broad-spectrum quinolone antibacterial with enhanced potency against Gram-positive bacteria, including multi-drug resistant Streptococcus pneumoniae, and retained potency against Gram-negative bacilli and bacterial strains resistant to other antibiotics....
2.
Mirochnick M, Cooper E, McIntosh K, Xu J, Lindsey J, Jacobus D, et al.
Antimicrob Agents Chemother
. 1999 Oct;
43(11):2586-91.
PMID: 10543733
Although dapsone is a commonly used alternative agent for prophylaxis against Pneumocystis carinii pneumonia in children intolerant to trimethoprim-sulfamethoxazole, there are few data that describe dapsone pharmacokinetics in children. We...
3.
Krogstad P, Wiznia A, Luzuriaga K, Dankner W, Nielsen K, Gersten M, et al.
Clin Infect Dis
. 1999 Aug;
28(5):1109-18.
PMID: 10452644
An open-label study was conducted of nelfinavir mesylate, given with reverse transcriptase inhibitors to human immunodeficiency virus 1 (HIV-1)-infected infants and children 3 months to 13 years of age. Doses...
4.
Mirochnick M, Capparelli E, Dankner W, Sperling R, Van Dyke R, Spector S
Antimicrob Agents Chemother
. 1998 Apr;
42(4):808-12.
PMID: 9559787
We used population analysis techniques to determine zidovudine (ZDV) pharmacokinetic parameters in 15 preterm neonates (mean gestational age, 29.4 weeks; mean birth weight, 1,230 g) at a mean age of...
5.
Whitley R, Cloud G, Gruber W, Storch G, Demmler G, Jacobs R, et al.
J Infect Dis
. 1997 May;
175(5):1080-6.
PMID: 9129069
Congenital cytomegalovirus (CMV) infection occurs in approximately 1% of newborns in the United States. A phase II evaluation was done of ganciclovir for the treatment of symptomatic congenital CMV infection....
6.
Lau L, Bin G, Jaovisidua S, Dankner W, Sartoris D
J Foot Ankle Surg
. 1997 Jan;
36(1):36-43.
PMID: 9031026
This study was performed to determine the cost effectiveness of radiologic imaging studies in diagnosing Pseudomonas aeruginosa infections after puncture wounds and the respective comparison of imaging and scintigraphy. Using...
7.
Trang J, Kidd L, Gruber W, Storch G, Demmler G, Jacobs R, et al.
Clin Pharmacol Ther
. 1993 Jan;
53(1):15-21.
PMID: 8380762
The pharmacokinetic characteristics of ganciclovir were determined in neonates (age range, 2 to 49 days) after an 1-hour intravenous infusion of a single dose of either 4 mg/kg (n =...
8.
Sullender W, Arvin A, Diaz P, Connor J, Straube R, Dankner W, et al.
Antimicrob Agents Chemother
. 1987 Nov;
31(11):1722-6.
PMID: 2829714
Eighteen children from 3 weeks to 6.9 years of age were given an oral acyclovir suspension for herpes simplex or varicella-zoster virus infections. Thirteen patients who were 6 months to...